By Michael Susin
Guardion Health Sciences on Tuesday requested the Nasdaq Stock Market to delist its stock as part of its liquidation and dissolution plans.
The clinical nutrition company said it expects to suspend trading of its stock prior to the opening of trading on Oct. 14, and for the official delisting to be effective Oct. 21.
The company also announced that it has appointed Mark Goldstone as interim president and interim chief executive, effective Oct. 18, replacing Jan Hall.
The liquidation plan was authorized by its shareholders on May 31. The dissolution follows the completion of the sale of the Viactiv brand and business, which left the company with minimal operations.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
October 01, 2024 09:24 ET (13:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments